ES2094797T3 - Una forma fisica de n-(4-(5-(ciclopentiloxicarbonilamino)-1-metil-indol-3-ilmetil)-3-metoxibenzoil)-2-metilbencenosulfonamida, un proceso para su preparacion y una composicion farmaceutica a base de la misma. - Google Patents
Una forma fisica de n-(4-(5-(ciclopentiloxicarbonilamino)-1-metil-indol-3-ilmetil)-3-metoxibenzoil)-2-metilbencenosulfonamida, un proceso para su preparacion y una composicion farmaceutica a base de la misma.Info
- Publication number
- ES2094797T3 ES2094797T3 ES91311505T ES91311505T ES2094797T3 ES 2094797 T3 ES2094797 T3 ES 2094797T3 ES 91311505 T ES91311505 T ES 91311505T ES 91311505 T ES91311505 T ES 91311505T ES 2094797 T3 ES2094797 T3 ES 2094797T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- metoxibenzoil
- methylbenzenosulfonamide
- ilmetil
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
UNA FORMA FISICA DE N-(4-(5-(CICLOPENTILOXICARBONIL)-AMINO-1-METIL-INDOL -3-ILMETIL)-3-METOXIBENZOIL)-2-METILBENZENOSULFONAMIDA SUSTANCIALMENTE LIBRE DE OTRAS FORMAS FISICAS, CUYA FORMA ES CRISTALINA, TIENE UN PODER DE DIFRACCION DE RAYOS X CON PICOS ESPECIFICOS OCURRIENDO A 20=8.1, 13.7, 16.4, 20.5 Y 23.7 UDOS EN 3370, 1670, 1525, 1490, 1280, 890, 870 Y 550 CM ELEVADO -1, UN PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS CONTENIENDOLO. TAMBIEN SE REVELA UNA PREPARACION FLUIDA DE SU FORMA FISICA, LA CUAL ESTA EN LA FORMA DE GRAGEAS SUAVES, Y PROCESO PARA LA OBTENCION DE ESTA PREPARACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027018A GB9027018D0 (en) | 1990-12-12 | 1990-12-12 | Heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2094797T3 true ES2094797T3 (es) | 1997-02-01 |
Family
ID=10686919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91311505T Expired - Lifetime ES2094797T3 (es) | 1990-12-12 | 1991-12-11 | Una forma fisica de n-(4-(5-(ciclopentiloxicarbonilamino)-1-metil-indol-3-ilmetil)-3-metoxibenzoil)-2-metilbencenosulfonamida, un proceso para su preparacion y una composicion farmaceutica a base de la misma. |
Country Status (28)
Country | Link |
---|---|
US (1) | US5294636A (es) |
EP (1) | EP0490649B1 (es) |
JP (1) | JP2650807B2 (es) |
KR (1) | KR100194479B1 (es) |
CN (2) | CN1032469C (es) |
AP (1) | AP286A (es) |
AT (1) | ATE145199T1 (es) |
AU (1) | AU656344B2 (es) |
CA (1) | CA2056067C (es) |
CZ (1) | CZ288151B6 (es) |
DE (1) | DE69123123T2 (es) |
DK (1) | DK0490649T3 (es) |
ES (1) | ES2094797T3 (es) |
FI (1) | FI101296B (es) |
GB (2) | GB9027018D0 (es) |
GR (1) | GR3021605T3 (es) |
HK (1) | HK81497A (es) |
HU (2) | HU213109B (es) |
IE (1) | IE914316A1 (es) |
IL (1) | IL100090A (es) |
MX (1) | MX9102475A (es) |
MY (1) | MY108629A (es) |
NZ (1) | NZ240940A (es) |
PH (1) | PH30041A (es) |
RU (1) | RU2107682C1 (es) |
SK (1) | SK279018B6 (es) |
TW (1) | TW222264B (es) |
ZA (1) | ZA919772B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455596B1 (de) * | 1990-05-04 | 1994-11-02 | Novartis AG | Substituierte Indole |
IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole) |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
GR1001368B (el) * | 1992-10-08 | 1993-10-29 | Ici Plc | Φαρμακευτικοί φορείς. |
DE4235133A1 (de) * | 1992-10-19 | 1994-04-21 | Bayer Ag | Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid |
HU222355B1 (hu) * | 1993-10-01 | 2003-06-28 | Astra Aktiebolag | Eljárás és berendezés finom gyógyszerhatóanyag-porok kezelésére és feldolgozására |
IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
GB9723985D0 (en) * | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
GB9726735D0 (en) * | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Pharmaceutical compositions |
IL139243A0 (en) * | 2000-10-24 | 2001-11-25 | Internat Specialty Products Is | Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof |
TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
US20090317476A1 (en) * | 2003-07-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050113410A1 (en) * | 2003-11-03 | 2005-05-26 | Mark Tawa | Pharmaceutical salts of zafirlukast |
JP2008531721A (ja) * | 2005-03-03 | 2008-08-14 | エラン・ファルマ・インターナショナル・リミテッド | 複素環式アミド誘導体のナノ粒子状組成物 |
US20070197467A1 (en) * | 2006-02-06 | 2007-08-23 | Srinivasulu Rangineni | Zafirlukast compositions |
US20090012146A1 (en) * | 2007-07-02 | 2009-01-08 | Giridhar Reddy Buggana | Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
US20090191183A1 (en) * | 2007-07-30 | 2009-07-30 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
WO2014012954A1 (en) | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
CN103396353B (zh) * | 2013-08-23 | 2015-05-20 | 海南通用三洋药业有限公司 | 一种扎鲁司特无定型态及其制备方法 |
CA2936332A1 (en) | 2014-01-22 | 2015-07-30 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier) |
PT109030B (pt) * | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
JP7272655B2 (ja) | 2017-01-30 | 2023-05-12 | ウェスタン ニュー イングランド ユニバーシティ | チオールイソメラーゼ阻害剤およびその使用 |
AU2022276190A1 (en) | 2021-05-19 | 2024-01-18 | Quercis Pharma AG | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis |
WO2023214391A1 (en) | 2022-05-06 | 2023-11-09 | Quercis Pharma AG | Method for treating cancers and neurological diseases using quercetin-containing compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161516A (en) * | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
-
1990
- 1990-12-12 GB GB909027018A patent/GB9027018D0/en active Pending
-
1991
- 1991-11-19 IL IL10009091A patent/IL100090A/en active IP Right Grant
- 1991-11-22 CA CA002056067A patent/CA2056067C/en not_active Expired - Fee Related
- 1991-12-06 TW TW080109583A patent/TW222264B/zh active
- 1991-12-09 HU HU913863A patent/HU213109B/hu not_active IP Right Cessation
- 1991-12-10 MX MX9102475A patent/MX9102475A/es not_active IP Right Cessation
- 1991-12-11 NZ NZ240940A patent/NZ240940A/en not_active IP Right Cessation
- 1991-12-11 DK DK91311505.1T patent/DK0490649T3/da active
- 1991-12-11 EP EP91311505A patent/EP0490649B1/en not_active Expired - Lifetime
- 1991-12-11 US US07/805,426 patent/US5294636A/en not_active Expired - Lifetime
- 1991-12-11 KR KR1019910022609A patent/KR100194479B1/ko not_active IP Right Cessation
- 1991-12-11 PH PH43618A patent/PH30041A/en unknown
- 1991-12-11 GB GB9126353A patent/GB2250743B/en not_active Expired - Lifetime
- 1991-12-11 RU SU5010266A patent/RU2107682C1/ru not_active IP Right Cessation
- 1991-12-11 SK SK3758-91A patent/SK279018B6/sk unknown
- 1991-12-11 DE DE69123123T patent/DE69123123T2/de not_active Expired - Lifetime
- 1991-12-11 IE IE431691A patent/IE914316A1/en not_active IP Right Cessation
- 1991-12-11 CZ CS19913758A patent/CZ288151B6/cs not_active IP Right Cessation
- 1991-12-11 MY MYPI91002300A patent/MY108629A/en unknown
- 1991-12-11 ZA ZA919772A patent/ZA919772B/xx unknown
- 1991-12-11 FI FI915825A patent/FI101296B/fi not_active IP Right Cessation
- 1991-12-11 AP APAP/P/1991/000341A patent/AP286A/en active
- 1991-12-11 AT AT91311505T patent/ATE145199T1/de not_active IP Right Cessation
- 1991-12-11 AU AU88995/91A patent/AU656344B2/en not_active Ceased
- 1991-12-11 ES ES91311505T patent/ES2094797T3/es not_active Expired - Lifetime
- 1991-12-11 CN CN91112791A patent/CN1032469C/zh not_active Expired - Fee Related
- 1991-12-11 JP JP3327439A patent/JP2650807B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-15 HU HU95P/P00208P patent/HU211125A9/hu unknown
- 1995-08-30 CN CN95115922A patent/CN1074411C/zh not_active Expired - Fee Related
-
1996
- 1996-11-14 GR GR960402814T patent/GR3021605T3/el unknown
-
1997
- 1997-06-19 HK HK81497A patent/HK81497A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2094797T3 (es) | Una forma fisica de n-(4-(5-(ciclopentiloxicarbonilamino)-1-metil-indol-3-ilmetil)-3-metoxibenzoil)-2-metilbencenosulfonamida, un proceso para su preparacion y una composicion farmaceutica a base de la misma. | |
ES2018706B3 (es) | Composicion polimera, un procedimiento para obtener una composicion polimera y el uso de dicha composicion. | |
ES510831A0 (es) | Un dispositivo portatil de lavado utilizable en particular para limpiar quirurgicamente las manos y brazos de un cirujano. | |
DE69109954T2 (de) | Selbsthebender und nichtausladender Lehnstuhl. | |
FR2705566B1 (fr) | Nouvelles compositions pharmaceutiques. | |
ITTO930338A0 (it) | Composizione adesiva, relativi procedimenti ed impiego | |
BR9508677A (pt) | Copolímero prodesso de preparação do mesmo e composição orgânica | |
ID28471A (id) | Komposisi-komposisi binatu yang mengandung bahan-bahan pendispersi polialkilenaimina teralkoksilasi | |
DE69115071D1 (de) | CVD-Diamantwerkstücke und ihre Herstellung. | |
ES2016976B3 (es) | Realizacion de una protesis de miembro y materiales para la misma. | |
MX9206687A (es) | Metodos para preparar formas sinterizadas y composiciones utilizadas en los mismos. | |
DE69400318T2 (de) | Silikon enthaltende Hautpflegezusammensetzungen | |
IT8921108A0 (it) | Siringa utilizzabile una sola volta. | |
NO910739L (no) | Sementeringsmateriale for olje, gass- og vannbroenner. | |
DE3676512D1 (de) | Fluorhaltiges copolymer und zusammensetzung die das copolymer enthaelt. | |
BR0317623A (pt) | Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram | |
IT1113425B (it) | Composizione termoplastica,particolarmente per ingessatura e simili applicazioni ortopediche | |
BR0008139B1 (pt) | composição lubrificante, e, uso de uma composição lubrificante. | |
DE69104961T2 (de) | Anwendung von Thiazolylalkoxyacrylaten in der Herstellung von Insektiziden und/oder Akanizide-Zusammensetzungen. | |
BR9510786B1 (pt) | uso de composiÇço de poliol para a preparaÇço de uma composiÇço nço farmacÊutica e nço alimentÍcia estÁvel. | |
FI821324L (fi) | Oxazolderivat | |
BR9106543A (pt) | Composicao para meios dinamicos,e,meios dinamicos vulcanizados | |
MX9200706A (es) | Composicion y uso. | |
ES2152315T3 (es) | Xamoneline tartrato. | |
IT7824578A0 (it) | Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 490649 Country of ref document: ES |